Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Cervical Conization Dimensions: 2022 Consensus Recommendations

Cervical Conization Dimensions: 2022 Consensus Recommendations

FromIJGC Podcast


Cervical Conization Dimensions: 2022 Consensus Recommendations

FromIJGC Podcast

ratings:
Length:
37 minutes
Released:
Oct 24, 2022
Format:
Podcast episode

Description

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Professor María Kyrgiou to discuss Cervical Conization Dimensions: 2022 Consensus Recommendations. Professor Mara Kyrgiou is a Professor at Imperial College London and a Consultant Surgeon in Gynaecology and Gynaecological Oncology at the West London Gynaecological Cancer Centre, Imperial Healthcare NHS Trust. She is the Head of Section of Gynaecological Oncology at Imperial College London. Her main clinical interest is minimal access and complex gynaecological cancer surgery.

Highlights:
- Local treatment techniques for cervical pre-invasive and early invasive disease were previously thought to be interchangeable with regards to treatment failure rates and associated with minor and infrequent complications.
- The findings of a network metaanalysis (Athanasiou Lancet Oncology 2022) suggest that more aggressive treatments (i.e., CKC, laser conisation) are associated with lower recurrence rates but higher risk for subsequent preterm birth.
- The risk of reproductive morbidity is directly associated with the length of the cone.
- This paper by ESGO/EFC/IFCPC describes a consensus terminology of the cone dimensions to make studies addressing effectiveness and safety of SIL/CIN treatment comparable and facilitate their use to tailor surveillance and antenatal management.
- The 2022 terminology should replace all previous terminologies, which will facilitate communication between clinicians and foster tailored treatment guidelines that balance obstetrical harm against therapeutic effectiveness.
- Universal agreed reporting will further facilitate communications among clinicians and pathologists, promote audit of practice and future research, and improve the quality of future meta-analyses.
Released:
Oct 24, 2022
Format:
Podcast episode

Titles in the series (100)

From June 2023, all our podcasts will move to https://ijgcbmj.podbean.com. You can continue with your subscription on your favourite podcast App. The International Journal of Gynecological Cancer publishes content on novel and relevant topics in the field of gynecologic cancer. IJGC Podcast features short interview segments with leading experts discussing the latest research in their respective areas. The podcasts will serve as an interactive and education experience for all our listeners. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.